Sort by
Search results
BIOPHEN Factor IX - new 1 mL presentation now available
BIOPHEN Factor IX (1)
Assay proposed for the measurement of factor IX activity in research applications.
Donor Plasma with Vitamin K antagonists (Warfarin-Sodium, Coumadin)
For all in vitro analyses that require vitamin K antagonist plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Emicizumab Calibrator
Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
Tris NaCl EDTA Buffer with heparin neutralisation, pH 7.85
For testing direct FXa inhibitors, especially with BIOPHEN Heparin LRT (ref. 221011 / 221013 / 221015), BIOPHEN Heparin 3 (ref. 221003), BIOPHEN Heparin 6 (ref. 221006) or BIOPHEN DiXaI (ref. 221030). This buffer totally neutralizes heparin present in the assay sample and renders a measurement totally specific for DiXaI.